Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial

[1]  Ofer Levy,et al.  Innate immunity of the newborn: basic mechanisms and clinical correlates , 2007, Nature Reviews Immunology.

[2]  Thomas J. Smith,et al.  2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Sheridan-Pereira,et al.  Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor Have Differential Effects on Neonatal and Adult Neutrophil Survival and Function , 2005, Pediatric Research.

[4]  B. Vohr,et al.  Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. , 2004, JAMA.

[5]  P. Nathan,et al.  Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Doré,et al.  G-CSF and GM-CSF for treating or preventing neonatal infections. , 2003, The Cochrane database of systematic reviews.

[7]  D. Isaacs,et al.  A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units , 2003, Archives of disease in childhood. Fetal and neonatal edition.

[8]  J. Bussel,et al.  Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants , 2002, The Pediatric infectious disease journal.

[9]  W. Poole,et al.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.

[10]  T. Huizinga,et al.  Low soluble FcRIII receptor demonstrates reduced neutrophil reserves in preterm neonates , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[11]  R. Carr Neutrophil Production and Function in Newborn Infants , 2000, British journal of haematology.

[12]  M. Lejeune,et al.  Defective functional activity and accelerated apoptosis in neutrophils from children with cancer are differentially corrected by granulocyte and granulocyte‐macrophage colony stimulating factors in vitro , 1999, British journal of haematology.

[13]  C. Doré,et al.  A Randomized, Controlled Trial of Prophylactic Granulocyte-Macrophage Colony-Stimulating Factor in Human Newborns Less Than 32 Weeks Gestation , 1999, Pediatrics.

[14]  E. L. La Gamma,et al.  Preliminary Report: rhG-CSF May Reduce the Incidence of Neonatal Sepsis in Prolonged Preeclampsia-associated Neutropenia , 1998, Pediatrics.

[15]  A. Leviton,et al.  Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. , 1998, Seminars in pediatric neurology.

[16]  G. Ricevuti,et al.  In vitro effects of GM-CSF on mature peripheral blood neutrophils. , 1998, International journal of molecular medicine.

[17]  N. Modi,et al.  Haemopoietic colony stimulating factors for preterm neonates , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[18]  M. Cairo,et al.  Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. , 1995, Blood.

[19]  W. Kachel,et al.  Neonatal Neutropenia in Low Birthweight Premature Infants , 1995, American journal of perinatology.

[20]  P. Sánchez,et al.  Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. , 1994, Pediatrics.

[21]  R. Faix,et al.  Increased nosocomial infection in neutropenic low birth weight (2000 grams or less) infants of hypertensive mothers. , 1992, The Journal of pediatrics.

[22]  R. Frenck,et al.  The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus. , 1990, The Journal of infectious diseases.

[23]  M. Cairo,et al.  Prophylactic or Simultaneous Administration of Recombinant Human Granulocyte Colony Stimulating Factor in the Treatment of Group B Streptococcal Sepsis in Neonatal Rats , 1990, Pediatric Research.

[24]  R. Christensen,et al.  Incidence, neutrophil kinetics, and nautral history of neonatal neutropenia associated with maternal hypertension , 1989, The New England journal of medicine.

[25]  H. Hill Biochemical, Structural, and Functional Abnormalities of Polymorphonuclear Leukocytes in the Neonate , 1987, Pediatric Research.

[26]  E. Liehl,et al.  Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates. , 1987, Blood.

[27]  R. Christensen,et al.  Exhaustion of mature marrow neutrophils in neonates with sepsis. , 1980, The Journal of pediatrics.

[28]  O. Derman,et al.  A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. , 2001, Pediatrics.

[29]  A. Fanaroff,et al.  A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. , 1999, The Journal of pediatrics.

[30]  P. Gray,et al.  Neonatal neutropenia associated with maternal hypertension poses a risk for nosocomial infection , 1999, European Journal of Pediatrics.

[31]  R. Christensen Neutrophil kinetics in the fetus and neonate. , 1989, The American journal of pediatric hematology/oncology.

[32]  C. Begley,et al.  Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor. , 1987, Blood.